| Are 90% of deaths from cancer caused by metastases? H Dillekås, MS Rogers, O Straume Cancer medicine 8 (12), 5574-5576, 2019 | 724 | 2019 |
| Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis Y Shaked, F Bertolini, S Man, MS Rogers, D Cervi, T Foutz, K Rawn, ... Cancer cell 7 (1), 101-111, 2005 | 463 | 2005 |
| Guidebook to the calcium-binding proteins MR Celio, TL Pauls A Sambrook and Tooze Publication at Oxford University Press, 1996 | 185 | 1996 |
| The mouse cornea micropocket angiogenesis assay MS Rogers, AE Birsner, RJ D'amato Nature protocols 2 (10), 2545-2550, 2007 | 162 | 2007 |
| S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice S Lentzsch, MS Rogers, R LeBlanc, AE Birsner, JH Shah, AM Treston, ... Cancer Research 62 (8), 2300-2305, 2002 | 110 | 2002 |
| Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma RJ D'Amato, S Lentzsch, KC Anderson, MS Rogers Seminars in Oncology 28 (6), 597-601, 2001 | 99 | 2001 |
| The effect of genetic diversity on angiogenesis MS Rogers, RJ D'Amato Experimental cell research 312 (5), 561-574, 2006 | 91 | 2006 |
| The tumor-sensitive calmodulin-like protein is a specific light chain of human unconventional myosin X MS Rogers, EE Strehler Journal of Biological Chemistry 276 (15), 12182-12189, 2001 | 82 | 2001 |
| Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment I Adini, K Ghosh, A Adini, ZL Chi, T Yoshimura, O Benny, KM Connor, ... The Journal of clinical investigation 124 (1), 425-436, 2014 | 76 | 2014 |
| Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein D Van Egeren, A Novokhodko, M Stoddard, U Tran, B Zetter, M Rogers, ... PloS one 16 (4), e0250780, 2021 | 69 | 2021 |
| Genetic loci that control vascular endothelial growth factor‐induced angiogenesis MS Rogers, RM Rohan, AE Birsner, RJ D'Amato The FASEB journal 17 (14), 1-18, 2003 | 69 | 2003 |
| Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy LM Cryan, MS Rogers Frontiers in bioscience: a journal and virtual library 16, 1574, 2011 | 67 | 2011 |
| Human calmodulin-like protein is an epithelial-specific protein regulated during keratinocyte differentiation MS Rogers, T Kobayashi, MR Pittelkow, EE Strehler Experimental cell research 267 (2), 216-224, 2001 | 54 | 2001 |
| Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth MS Rogers, KA Christensen, AE Birsner, SM Short, DJ Wigelsworth, ... Cancer research 67 (20), 9980-9985, 2007 | 52 | 2007 |
| Genetic loci that control the angiogenic response to basic response to basic fibroblast growth factor MS Rogers, RM Rohan, AE Birsner, RJ D'amato The FASEB journal 18 (10), 1050-1059, 2004 | 51 | 2004 |
| A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein MS Rogers, LM Cryan, KA Habeshian, L Bazinet, TP Caldwell, ... PloS one 7 (6), e39911, 2012 | 45 | 2012 |
| Common polymorphisms in angiogenesis MS Rogers, RJ D’Amato Cold Spring Harbor Perspectives in Medicine 2 (11), a006510, 2012 | 43 | 2012 |
| 3-Amino-Phthalimido-Glutarimide (S-3APG) Inhibits Angiogenesis and Growth in Drug Resistant Multiple Myeloma (MM) in vivo S Lentsch, M Rogers, R Leblanc, A Birsner, J Shah, K Anderson, ... Abstract, 1976 | 42 | 1976 |
| 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose Inhibits Angiogenesis via Inhibition of Capillary Morphogenesis Gene 2 LM Cryan, L Bazinet, KA Habeshian, S Cao, J Clardy, KA Christensen, ... Journal of medicinal chemistry 56 (5), 1940-1945, 2013 | 37 | 2013 |
| Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugs V Fattori, NS Franklin, R Gonzalez-Cano, D Peterse, A Ghalali, E Madrian, ... Pain 161 (6), 1321-1331, 2020 | 32 | 2020 |
Robert DAmatoE-mail confirmado em childrens.harvard.edu
